Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-08-01 Sale | 2023-08-11 8:00 pm | Surface Oncology Inc. | SURF | FEES JESSICA Chief Financial Officer | 9,434 | $0.94 | $8,868 | 101,915 (Direct) | View |
| 2022-08-03 Sale | 2022-08-05 8:00 pm | Surface Oncology Inc. | SURF | FEES JESSICA Chief Financial Officer | 5,980 | $1.72 | $10,286 | 111,349 (Direct) | View |
| 2021-07-21 Sale | 2022-01-14 8:30 pm | Surface Oncology Inc. | SURF | FEES JESSICA Chief Financial Officer | 19,854 | $6.1 | $121,109 | 79,329 (Direct) | View |
| 2021-02-08 Sale | 2021-02-09 8:00 pm | Surface Oncology Inc. | SURF | FEES JESSICA See Remarks | 1,500 | $12.45 | $18,675 | 99,183 (Direct) | View |
| 2021-02-01 Sale | 2021-02-03 8:00 pm | Surface Oncology Inc. | SURF | FEES JESSICA See Remarks | 1,500 | $11.19 | $16,785 | 100,683 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-09-08 Disposition | 2023-09-08 4:00 pm | N/A N/A | Surface Oncology Inc. | SURF | FEES JESSICA Chief Financial Officer | 251,915 | $0 | 0 (Direct) | View |
| 2023-03-01 Option Award | 2023-03-03 8:00 pm | N/A 2033-03-01 | Surface Oncology Inc. | SURF | FEES JESSICA Chief Financial Officer | 150,000 | $0 | 150,000 (Direct) | View |
| 2022-03-01 Option Award | 2022-03-03 8:00 pm | N/A 2032-03-01 | Surface Oncology Inc. | SURF | FEES JESSICA Chief Financial Officer | 146,000 | $0 | 225,329 (Direct) | View |
| 2021-05-03 Option Award | 2021-05-05 6:45 pm | N/A 2031-05-03 | Surface Oncology Inc. | SURF | FEES JESSICA See Remarks | 30,000 | $0 | 30,000 (Direct) | View |
| 2021-03-01 Option Award | 2021-03-03 8:16 pm | N/A 2031-03-01 | Surface Oncology Inc. | SURF | FEES JESSICA See Remarks | 68,000 | $0 | 68,000 (Direct) | View |
| 2020-11-25 Exercise | 2020-11-27 8:00 pm | N/A N/A | Surface Oncology Inc. | SURF | FEES JESSICA See Remarks | 174 | $4.27 | 145,196 (Direct) | View |
| 2020-11-25 Exercise | 2020-11-27 8:00 pm | N/A N/A | Surface Oncology Inc. | SURF | FEES JESSICA See Remarks | 227 | $4.136 | 145,196 (Direct) | View |
| 2020-11-25 Exercise | 2020-11-27 8:00 pm | N/A N/A | Surface Oncology Inc. | SURF | FEES JESSICA See Remarks | 982 | $5.412 | 145,196 (Direct) | View |
| 2020-11-25 Exercise | 2020-11-27 8:00 pm | N/A 2026-12-09 | Surface Oncology Inc. | SURF | FEES JESSICA See Remarks | 1,383 | $0 | 145,196 (Direct) | View |
| 2020-10-28 Exercise | 2020-10-30 8:30 pm | N/A N/A | Surface Oncology Inc. | SURF | FEES JESSICA See Remarks | 122 | $4.27 | 115,560 (Direct) | View |
| 2020-10-28 Exercise | 2020-10-30 8:30 pm | N/A N/A | Surface Oncology Inc. | SURF | FEES JESSICA See Remarks | 4,773 | $4.136 | 115,560 (Direct) | View |
| 2020-10-28 Exercise | 2020-10-30 8:30 pm | N/A 2026-12-09 | Surface Oncology Inc. | SURF | FEES JESSICA See Remarks | 4,895 | $0 | 115,560 (Direct) | View |
| 2020-02-03 Option Award | 2020-02-05 4:05 pm | N/A 2030-02-03 | Surface Oncology Inc. | SURF | FEES JESSICA See Remarks | 45,000 | $0 | 140,905 (Direct) | View |